Tag Archives: Bayh-Dole Act

Technology Transfer: Promoting Public-Private Collaborations for Innovation

Jim Greenwood

BIO President and CEO Jim Greenwood penned an op-ed for the September issue of BioPharm International on the importance of technology transfer from academia to industry, as encouraged by the Bayh-Dole Act of 1980. The Bayh-Dole Act, which permits and encourages industry to partner with research universities to turn federally-funded basic research into new and valuable products, is a critical factor in driving America’s innovation economy. Because of this legislation, the U.S. leads the world Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

University Licensing Survey 2010 – AUTM

AUTM is set to release their AUTM Licensing Activity Survey Summary: FY 2010 in the fall of this year for both the U.S. and Canada.  AUTM issued a AUTM 2010 survey highlights to wet the appetite. Highlights: -The number of startups formed increased 10.6%.  651 startup companies formed of which 498 had their primary place of business in the licensing institution’s home state. -Number of licenses/options executed to startups increased 14%.  4,284 licenses executed and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Taiwan’s Translational Research (or lack thereof)

Taiwan Flag - Matthew Fang

Brady Huggett concludes in this article that, “… perhaps the biggest strike against Taiwan is a lack of translational research. There is no collective mindset that envisions products from research. And if biotech is to drive the future economies of countries around the globe, there has to be nationwide efforts to turn academic research and publicly-funded lab work into something that can benefit patients and be sold. We’ve talked about it before on this blog Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR

Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry Organization (BIO), Association of American Universities (AAU), American Council on Education (ACE), Association of Public and Land-grant Universities (APLU), Association of University Technology Managers (AUTM), and Council on Governmental Relations (COGR) because of its potential impact on university technology transfer, on development and commercialization of university-generated Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

Foley & Lardner article on the history of the Chinese Bayh-Dole Act

China Bayh-Dole Act: A Framework Fundamental to Achieving the Economic Potential of China’s National Patent Development Strategy (2011 – 2020) By Max Lin, Foley & Lardner LLP This article is part of our Spring 2011 edition of Legal News: China Quarterly Newsletter, Eye on China. China’s National Patent Development Strategy (2011 – 2020) (Plan) was announced in November 2010. The proposed measures focus on enhancing China’s IP system and encouraging local individuals, institutions, and companies to Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,